| Malignant Ovarian Neoplasm predicts response to …PREDICTS_RESPONSE_TO51 of 51show fewer |
|---|
| in context · predicts response to | BRCA1 Mutationother → predicts response to Olaparib 2 source records aggregated | sensitivity | A | Malignant Ovarian Neoplasm | 2 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 Mutationother → predicts response to Rucaparib 2 source records aggregated | sensitivity | A | Malignant Ovarian Neoplasm | 2 | Curated | civic | graph → |
| in context · predicts response to | BRCA1 Mutationother → predicts response to Rucaparib 2 source records aggregated | sensitivity | A | Malignant Ovarian Neoplasm | 2 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 Mutationother → predicts response to Olaparib | sensitivity | A | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 Mutationother → predicts response to Rucaparib 2 source records aggregated | sensitivity | B | Malignant Ovarian Neoplasm | 2 | Curated | civic | graph → |
| in context · predicts response to | BRCA1 Mutationother → predicts response to Rucaparib 2 source records aggregated | sensitivity | B | Malignant Ovarian Neoplasm | 2 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 Mutationother → predicts response to Olaparib 2 source records aggregated | sensitivity | B | Malignant Ovarian Neoplasm | 2 | Curated | civic | graph → |
| in context · predicts response to | BRCA1 Mutationother → predicts response to Olaparib 2 source records aggregated | sensitivity | B | Malignant Ovarian Neoplasm | 2 | Curated | civic | graph → |
| in context · predicts response to | TOP1 EXPRESSIONexpression → predicts response to Topotecan | sensitivity | B | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TOP1 EXPRESSIONexpression → predicts response to Carboplatin | sensitivity | B | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TOP1 EXPRESSIONexpression → predicts response to Cyclophosphamide | sensitivity | B | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | FNTB RS11623866promoter_mutation → predicts response to Lonafarnib | resistance | B | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Vemurafenib | sensitivity | B | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA1 Loss-of-functionloss_of_heterozygosity → predicts response to Talazoparib | sensitivity | B | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 Loss-of-function → predicts response to Talazoparib | sensitivity | B | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TP53 Overexpressionexpression → predicts response to Carboplatin | resistance | B | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TP53 Overexpressionexpression → predicts response to Cisplatin | resistance | B | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 Mutationother → predicts response to Cediranib | sensitivity | B | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA1 Mutationother → predicts response to Cediranib | sensitivity | B | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA1 Underexpressionexpression → predicts response to Platinum Compound | sensitivity | B | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA1 Underexpressionexpression → predicts response to Taxane Compound | sensitivity | B | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABCB1 S893TSNV → predicts response to Paclitaxel | sensitivity | B | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TP53 ALTERATIONother → predicts response to Carboplatin | resistance | B | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TP53 ALTERATIONother → predicts response to Cisplatin | resistance | B | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 Loss-of-function → predicts response to Olaparib | sensitivity | B | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA1 Loss-of-functionloss_of_heterozygosity → predicts response to Olaparib | sensitivity | B | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 V211ISNV → predicts response to Rucaparib | sensitivity | C | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 R2336PSNV → predicts response to Rucaparib | sensitivity | C | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 V211LSNV → predicts response to Rucaparib | sensitivity | C | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 V159MSNV → predicts response to Rucaparib | sensitivity | C | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 M1?SNV → predicts response to Rucaparib | sensitivity | C | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 M1RSNV → predicts response to Rucaparib | sensitivity | C | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA1 Q1467*SNV → predicts response to Rucaparib | sensitivity | C | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TP53 Y234CSNV → predicts response to Cisplatin | resistance | C | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TP53 Y234CSNV → predicts response to Carboplatin | resistance | C | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TP53 R273LSNV → predicts response to Cisplatin | resistance | C | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TP53 R273LSNV → predicts response to Carboplatin | resistance | C | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | CCNE1 Overexpressionexpression → predicts response to CDK Inhibitor SNS-032 | sensitivity | D | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Lossdeletion_cna → predicts response to Cisplatin | resistance | D | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ASNS Amplificationamplification → predicts response to Asparaginase | resistance | D | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ASS1 Lossdeletion_cna → predicts response to Carboplatin | resistance | D | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ASS1 Lossdeletion_cna → predicts response to Taxol | resistance | D | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ASS1 Lossdeletion_cna → predicts response to Cisplatin | resistance | D | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KRAS G12DSNV → predicts response to Cetuximab | resistance | D | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | VPS37A Underexpressionexpression → predicts response to Cetuximab | resistance | D | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | CDKN2A Lossdeletion_cna → predicts response to Palbociclib | sensitivity | D | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KRAS Mutationother → predicts response to Decitabine | sensitivity | D | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | DNMT1 EXPRESSIONexpression → predicts response to Decitabine | sensitivity | D | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NRG1 Expressionexpression → predicts response to Seribantumab | sensitivity | D | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | SYK OVEREXPRESSIONexpression → predicts response to Paclitaxel | resistance | D | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | LRP1B Exon 12-22 Deletiondeletion_cna → predicts response to Doxorubicin | resistance | D | Malignant Ovarian Neoplasm | 1 | Curated | civic | graph → |